Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders

被引：2
作者：
Samarasena, Jason B. [2 ]
Hu, Ke-Qin [1 ]
机构：
[1] Univ Calif Irvine, Irvine Sch Med, Div Gastroenterol & Hepatol, Orange, CA 92868 USA
[2] Univ Calif Irvine, Med Ctr, Div Gastroenterol, Orange, CA 92868 USA
来源：
CLINICS IN LIVER DISEASE | 2011年 / 15卷 / 01期
关键词：
Hepatobiliary manifestations; Liver disease; Primary sclerosing cholangitis; Celiac disease; Whipple's disease; Parenteral nutrition; PRIMARY SCLEROSING CHOLANGITIS; TOTAL PARENTERAL-NUTRITION; INFLAMMATORY-BOWEL-DISEASE; PRIMARY BILIARY-CIRRHOSIS; ANTITISSUE TRANSGLUTAMINASE ANTIBODIES; CHOLESTATIC LIVER-DISEASE; PLASMA-FREE CHOLINE; GLUTEN-FREE DIET; QUALITY-OF-LIFE; CELIAC-DISEASE;
D O I：
10.1016/j.cld.2010.09.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatobiliary manifestations of gastrointestinal and nutritional disorders can occur as part of the clinical spectrum of the underlying disease or as a consequence of the treatment of the disease. This article reviews aspects of pathogenesis, diagnosis, and management of hepatobiliary manifestations associated with a selection of gastrointestinal and nutritional disorders including inflammatory bowel disease, celiac disease, Whipple's disease, and parenteral nutrition associated disorders.
引用
收藏
页码：89 / +
页数：23
相关论文
共 123 条
  • [1] PRIMARY SCLEROSING CHOLANGITIS WITH NORMAL SERUM ALKALINE-PHOSPHATASE ACTIVITY
    BALASUBRAMANIAM, K
    WIESNER, RH
    LARUSSO, NF
    [J]. GASTROENTEROLOGY, 1988, 95 (05) : 1395 - 1398
  • [2] Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community
    Bambha, K
    Kim, WR
    Talwalkar, J
    Torgerson, H
    Benson, JT
    Therneau, TM
    Loftus, EV
    Yawn, BP
    Dickson, ER
    Melton, LJ
    [J]. GASTROENTEROLOGY, 2003, 125 (05) : 1364 - 1369
  • [3] Chronic unexplained hypertransaminasemia may be caused by occult celiac disease
    Bardella, MT
    Vecchi, M
    Conte, D
    Del Ninno, E
    Fraquelli, M
    Pacchetti, S
    Minola, E
    Landoni, M
    Cesana, BM
    De Franchis, R
    [J]. HEPATOLOGY, 1999, 29 (03) : 654 - 657
  • [4] BARDELLA MT, 1995, HEPATOLOGY, V22, P833, DOI 10.1002/hep.1840220322
  • [5] Bergasa Nora V, 2003, Clin Liver Dis, V7, P879, DOI 10.1016/S1089-3261(03)00105-3
  • [6] Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
    Bergquist, Annika
    Montgomery, Scott M.
    Bahmanyar, Shahram
    Olsson, Rolf
    Danielsson, Ake
    Lindgren, Stefan
    Prytz, Hanne
    Hultcrantz, Rolf
    Loof, Lars
    Sandberg-Gertzen, Hanna
    Almer, Sven
    Askling, Johan
    Ehlin, Anna
    Ekbom, Anders
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (08) : 939 - 943
  • [7] 10-YEARS EXPERIENCE WITH METHOTREXATE AND FOLINIC ACID AS PRIMARY THERAPY FOR GESTATIONAL TROPHOBLASTIC DISEASE
    BERKOWITZ, RS
    GOLDSTEIN, DP
    BERNSTEIN, MR
    [J]. GYNECOLOGIC ONCOLOGY, 1986, 23 (01) : 111 - 118
  • [8] The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis
    Boberg, KM
    Spurkland, A
    Rocca, G
    Egeland, T
    Saarinen, S
    Mitchell, S
    Broomé, U
    Chapman, R
    Olerup, O
    Pares, A
    Rosina, F
    Schrumpf, E
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (08) : 886 - 890
  • [9] Bonamico M, 1986, Minerva Pediatr, V38, P959
  • [10] L-CARNITINE THERAPY IN HOME PARENTERAL-NUTRITION PATIENTS WITH ABNORMAL LIVER TESTS AND LOW PLASMA CARNITINE CONCENTRATIONS
    BOWYER, BA
    MILES, JM
    HAYMOND, MW
    FLEMING, CR
    [J]. GASTROENTEROLOGY, 1988, 94 (02) : 434 - 438
12345678910